These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas. Chi DS, Zivanovic O, Levinson KL, Kolev V, Huh J, Dottino J, Gardner GJ, Leitao MM, Levine DA, Sonoda Y, Abu-Rustum NR, Brown CL, Barakat RR. Gynecol Oncol; 2010 Oct; 119(1):38-42. PubMed ID: 20609464 [Abstract] [Full Text] [Related]
8. Safety and efficacy of low anterior en bloc resection as part of cytoreductive surgery for patients with ovarian cancer. Obermair A, Hagenauer S, Tamandl D, Clayton RD, Nicklin JL, Perrin LC, Ward BG, Crandon AJ. Gynecol Oncol; 2001 Oct; 83(1):115-20. PubMed ID: 11585422 [Abstract] [Full Text] [Related]
10. Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapy. Estes JM, Leath CA, Straughn JM, Rocconi RP, Kirby TO, Huh WK, Barnes MN. J Am Coll Surg; 2006 Oct; 203(4):527-32. PubMed ID: 17000397 [Abstract] [Full Text] [Related]
12. Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or less. Chi DS, Ramirez PT, Teitcher JB, Mironov S, Sarasohn DM, Iyer RB, Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Levine DA, Brown CL, Aghajanian C, Gershenson DM, Hoskins WJ, Hricak H, Barakat RR. J Clin Oncol; 2007 Nov 01; 25(31):4946-51. PubMed ID: 17971592 [Abstract] [Full Text] [Related]
13. Sites of bowel resected to achieve optimal ovarian cancer cytoreduction: implications regarding surgical management. Hoffman MS, Griffin D, Tebes S, Cardosi RJ, Martino MA, Fiorica JV, Lockhart JL, Grendys EC. Am J Obstet Gynecol; 2005 Aug 01; 193(2):582-6; discussion 586-8. PubMed ID: 16098902 [Abstract] [Full Text] [Related]
14. Low colorectal anastomosis after radical pelvic surgery: a risk factor analysis. Mirhashemi R, Averette HE, Estape R, Angioli R, Mahran R, Mendez L, Cantuaria G, Penalver M. Am J Obstet Gynecol; 2000 Dec 01; 183(6):1375-9; discussion 1379-80. PubMed ID: 11120499 [Abstract] [Full Text] [Related]
16. The management and outcome of anastomotic leaks in colorectal surgery. Khan AA, Wheeler JM, Cunningham C, George B, Kettlewell M, Mortensen NJ. Colorectal Dis; 2008 Jul 01; 10(6):587-92. PubMed ID: 18070185 [Abstract] [Full Text] [Related]
17. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. Di Giorgio A, Naticchioni E, Biacchi D, Sibio S, Accarpio F, Rocco M, Tarquini S, Di Seri M, Ciardi A, Montruccoli D, Sammartino P. Cancer; 2008 Jul 15; 113(2):315-25. PubMed ID: 18473354 [Abstract] [Full Text] [Related]
18. The role of cytoreductive surgery for colon cancer metastatic to the ovary. McCormick CC, Giuntoli RL, Gardner GJ, Schulick RD, Judson K, Ronnett BM, Vang R, Bristow RE. Gynecol Oncol; 2007 Jun 15; 105(3):791-5. PubMed ID: 17408727 [Abstract] [Full Text] [Related]